Darzalex faspro 1,800MG-30,000 15ML
Ended Awarded Last action
- Contract number
- SPE2DR26F20WQ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,577
Award facts
- Contract value 100% obligated
- $19,577.31 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $19,577.31 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of DARZALEX FASPRO 1,800MG-30,000 15ML, a specialized pharmaceutical product. The delivery order, issued on January 16, 2026, carries an ultimate completion date of February 9, 2026, and was awarded on a non-set-aside, competitive basis. The performance location is the company's corporate office in Conshohocken, Pennsylvania. This delivery order represents a task order issued under AmerisourceBergen's parent company Cencora, Inc.'s comprehensive Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999.99 million through December 31, 2031, which serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, maintains a significant presence in federal medical procurement through its extensive portfolio of competitive contract awards with DLA and the Defense Health Agency. The company's federal contract awards demonstrate consistent capability in delivering a broad spectrum of pharmaceutical products across multiple therapeutic domains, including specialty medications, vaccines, and medical devices to military treatment facilities and veteran healthcare programs. As a subsidiary of Cencora, Inc., AmerisourceBergen leverages the parent organization's established infrastructure and $999.99 million DLA contract vehicle to efficiently fulfill government requirements for essential pharmaceutical commodities required across the Department of Defense medical supply chain.
Quick answers
Who was awarded contract SPE2DR26F20WQ?
SPE2DR26F20WQ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 16, 2026.
How much is contract SPE2DR26F20WQ worth?
The government has obligated $19,577 on SPE2DR26F20WQ.
Is contract SPE2DR26F20WQ an order under another contract?
Yes. SPE2DR26F20WQ is a delivery order under SPE2DR25D3301, an indefinite delivery contract.
Was contract SPE2DR26F20WQ competed?
The extent of competition for SPE2DR26F20WQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award